Barbara Mora

Varese, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 71 publications

Characterization of a Newly Discovered Non-Coding Variant in the EPO Gene Identified in Two Unrelated Italian Pedigrees With Erythrocytosis.

Characterization of a Newly Discovered Non-Coding Variant in the EPO Gene Identified in Two Unrelated Italian Pedigrees With Erythrocytosis.

Journal: American journal of hematology

Published: October 31, 2025

The influence of patient engagement and self-efficacy on self-care in myeloproliferative neoplasms: A mediation analysis.

The influence of patient engagement and self-efficacy on self-care in myeloproliferative neoplasms: A mediation analysis.

Journal: European journal of oncology nursing : the official journal of European Oncology Nursing Society

Published: October 29, 2025

Health Care Utilization Databases obtained from health system inform outcome for ruxolitinib treatment in patients with myelofibrosis.

Health Care Utilization Databases obtained from health system inform outcome for ruxolitinib treatment in patients with myelofibrosis.

Journal: HemaSphere

Published: October 07, 2025

Genomic profiling for decision-making in post-polycythemia vera and post-essential thrombocythemia myelofibrosis.

Genomic profiling for decision-making in post-polycythemia vera and post-essential thrombocythemia myelofibrosis.

Journal: Blood

Published: August 26, 2025

The 2024 Three-Strata Baseline Anemia Definition of the Revised IWG-ELN Criteria Dissects Survival in Ruxolitinib-Treated Myelofibrosis Patients.

The 2024 Three-Strata Baseline Anemia Definition of the Revised IWG-ELN Criteria Dissects Survival in Ruxolitinib-Treated Myelofibrosis Patients.

Journal: American journal of hematology

Published: March 05, 2025

CALR-mutated myeloproliferative neoplasms.

CALR-mutated myeloproliferative neoplasms.

Journal: Leukemia & lymphoma

Published: February 17, 2025

CD44 Participates to Extramedullary Haematopoiesis Onset by Mediating the Interplay Between Monocytes and Haematopoietic Stem Cells in Myelofibrosis.

CD44 Participates to Extramedullary Haematopoiesis Onset by Mediating the Interplay Between Monocytes and Haematopoietic Stem Cells in Myelofibrosis.

Journal: Journal of cellular and molecular medicine

Published: January 30, 2025

Circulating Levels of PF4/CXCL4 in Patients With BCR::ABL1-Negative Myeloproliferative Neoplasms: A New Potential Prognostic Factor for Disease Progression.

Circulating Levels of PF4/CXCL4 in Patients With BCR::ABL1-Negative Myeloproliferative Neoplasms: A New Potential Prognostic Factor for Disease Progression.

Journal: Hematological oncology

Published: January 10, 2025

Cytopenic overt primary myelofibrosis at presentation: Analysis of outcomes in the prospective, real-world ERNEST-2 registry.

Cytopenic overt primary myelofibrosis at presentation: Analysis of outcomes in the prospective, real-world ERNEST-2 registry.

Journal: HemaSphere

Published: July 26, 2024

Treatment-free remission as a new goal in the management of chronic myeloid leukemia: Clinical and biological aspects.

Treatment-free remission as a new goal in the management of chronic myeloid leukemia: Clinical and biological aspects.

Journal: Hematological oncology

Published: July 14, 2024

Prognostic and Predictive Models in Myelofibrosis.

Prognostic and Predictive Models in Myelofibrosis.

Journal: Current hematologic malignancy reports

Published: July 02, 2024

Editorial: Biological and clinical implications of the mutational landscape in myeloproliferative neoplasms.

Editorial: Biological and clinical implications of the mutational landscape in myeloproliferative neoplasms.

Journal: Frontiers in oncology

Published: June 25, 2024

Showing 1-12 of 71

Last Updated: 09/26/2026